Nucleolin-aptamer therapy in retinoblastoma: molecular changes and mass spectrometry-based imaging
Retinoblastoma (RB) is an intraocular childhood tumor which, if left untreated, leads to blindness and mortality. Nucleolin (NCL) protein which is differentially expressed on the tumor cell surface, binds ligands and regulates carcinogenesis and angiogenesis. We found that NCL is over expressed in R...
Saved in:
Main Authors: | Nithya Subramanian (Author), Amitava Srimany (Author), Jagat R Kanwar (Author), Rupinder K Kanwar (Author), Balachandran Akilandeswari (Author), Pukhraj Rishi (Author), Vikas Khetan (Author), Madavan Vasudevan (Author), Thalappil Pradeep (Author), Subramanian Krishnakumar (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding the mechano and chemo response of retinoblastoma tumor cells
by: Gopal Divya, et al.
Published: (2022) -
Characterization and Molecular Mechanism of Peptide-Conjugated Gold Nanoparticle Inhibiting p53-HDM2 Interaction in Retinoblastoma
by: Sushma Kalmodia, et al.
Published: (2017) -
Nucleolin-Targeting AS1411 Aptamer-Conjugated Nanospheres for Targeted Treatment of Glioblastoma
by: Kyeongjin Seo, et al.
Published: (2024) -
Locking up the AS1411 Aptamer with a Flanking Duplex: Towards an Improved Nucleolin-Targeting
by: André Miranda, et al.
Published: (2021) -
Development of a novel PROTAC using the nucleic acid aptamer as a targeting ligand for tumor selective degradation of nucleolin
by: Lin Zhang, et al.
Published: (2022)